EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:6129 - ketorolac
| Formula | C15H13NO3 |
| Net Charge | 0 |
| Average Mass | 255.273 |
| Monoisotopic Mass | 255.08954 |
| SMILES | O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O |
| InChI | InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19) |
| InChIKey | OZWKMVRBQXNZKK-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | cyclooxygenase 1 inhibitor A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 1. antibacterial agent A substance (or active part thereof) that kills or slows the growth of bacteria. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. cyclooxygenase 2 inhibitor A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 2. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. non-steroidal anti-inflammatory drug An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. anti-inflammatory agent Any compound that has anti-inflammatory effects. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. vulnerary A drug used in treating and healing of wounds. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ketorolac (CHEBI:6129) has part (R)-ketorolac (CHEBI:76227) |
| ketorolac (CHEBI:6129) has part (S)-ketorolac (CHEBI:76228) |
| ketorolac (CHEBI:6129) has role analgesic (CHEBI:35480) |
| ketorolac (CHEBI:6129) has role anti-inflammatory agent (CHEBI:67079) |
| ketorolac (CHEBI:6129) has role antibacterial agent (CHEBI:33282) |
| ketorolac (CHEBI:6129) has role antineoplastic agent (CHEBI:35610) |
| ketorolac (CHEBI:6129) has role cardiovascular drug (CHEBI:35554) |
| ketorolac (CHEBI:6129) has role cyclooxygenase 1 inhibitor (CHEBI:50630) |
| ketorolac (CHEBI:6129) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ketorolac (CHEBI:6129) has role non-steroidal anti-inflammatory drug (CHEBI:35475) |
| ketorolac (CHEBI:6129) has role ophthalmology drug (CHEBI:66981) |
| ketorolac (CHEBI:6129) has role vulnerary (CHEBI:73336) |
| ketorolac (CHEBI:6129) is a racemate (CHEBI:60911) |
| ketorolac (CHEBI:6129) is conjugate acid of ketorolac(1−) (CHEBI:76229) |
| Incoming Relation(s) |
| ketorolac(1−) (CHEBI:76229) is conjugate base of ketorolac (CHEBI:6129) |
| IUPAC Name |
|---|
| rac-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid |
| INNs | Source |
|---|---|
| ketorolac | ChemIDplus |
| kétorolac | WHO MedNet |
| ketorolaco | ChemIDplus |
| ketorolacum | ChemIDplus |
| Synonyms | Source |
|---|---|
| (±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid | ChemIDplus |
| rac-ketorolac | ChEBI |
| (±)-ketorolac | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Reaxys:413572 | Reaxys |
| CAS:74103-06-3 | KEGG COMPOUND |
| CAS:74103-06-3 | ChemIDplus |
| CAS:74103-06-3 | KEGG DRUG |
| Citations |
|---|